human | Q5 |
P496 | ORCID iD | 0000-0003-4164-5561 |
P1153 | Scopus author ID | 26631163000 |
P108 | employer | University of Galway | Q644478 |
P735 | given name | Michael | Q4927524 |
Michael | Q4927524 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q50714110 | "Excuse me:" teaching interns to speak up. |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q92945512 | A Review of the Impact of Neoadjuvant Chemotherapy on Breast Surgery Practice and Outcomes |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q38264727 | A review of sentinel lymph node biopsy for thin melanoma |
Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
Q43131010 | Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety |
Q40585434 | Analysis of subsequent publication and impact of abstracts presented at the Sir Peter Freyer Surgical Symposium: Focus on the Plenary Session |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
Q35061513 | Awareness and uptake of family screening in patients diagnosed with colorectal cancer at a young age. |
Q44288178 | CYP3A variation, premenopausal estrone levels, and breast cancer risk |
Q38644736 | Clinical and economic benefit of general practitioner integration to a symptomatic breast service |
Q33766513 | Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer |
Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q35768989 | Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs |
Q99419831 | Effect of Breast Cancer and Adjuvant Therapy on Adipose-Derived Stromal Cells: Implications for the Role of ADSCs in Regenerative Strategies for Breast Reconstruction |
Q44569975 | Endoscopic management of common duct stones with laparoscopic cholecystectomy |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q38832499 | Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer |
Q40661127 | FNAC and frozen section correlations with definitive histology in thyroid diseases |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q58599232 | Hydrogels in adipose tissue engineering-Potential application in post-mastectomy breast regeneration |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q42377099 | Investigating the association of rs2910164 with cancer predisposition in an Irish cohort |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q35057393 | Mismatch repair protein expression in colorectal cancer |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q64952029 | Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy. |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
Q24672741 | Pathology and clinical relevance of radial scars: a review |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q38918206 | Prospective comparison of outcome after treatment for triple-negative and non-triple-negative breast cancer |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q71816302 | Results of a prospective randomized trial using DTIC and interferon as adjuvant therapy for stage I malignant melanoma |
Q92359744 | Serial CRP levels following oesophagectomy: a marker for anastomotic dehiscence |
Q92695694 | Super-resolution radar imaging for breast cancer detection with microwaves: the integrated information selection criteria |
Q35068495 | The acquisition and retention of urinary catheterisation skills using surgical simulator devices: teaching method or student traits |
Q49720647 | The clinical utility of pre-operative neutrophil-to-lymphocyte ratio as a predictor of outcomes in patients undergoing elective laparoscopic cholecystectomy. |
Q48359353 | The future of UK/Irish surgery: A European solution |
Q34376320 | The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre |
Q46928066 | The oncologic safety and practicality of breast conservation surgery in large breast tumors 5 centimeters or more |
Q35535359 | The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer |
Q79259558 | The value of axillary lymphadenectomy |
Q47922430 | Total systemic ropivacaine concentrations following aerosolized intraperitoneal delivery using the AeroSurge |
Q47694980 | You've Got to Hand It to Them: Assessing Final Year Medical Students Knowledge of Hand Anatomy and Pathology |
Search more.